BIOAVAILABILITY OF LOW-DOSE VS HIGH-DOSE 6-MERCAPTOPURINE

被引：18

作者：

ARNDT, CAS

BALIS, FM

MCCULLY, CL

JEFFRIES, SL

DOHERTY, K

MURPHY, R

POPLACK, DG

机构：

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1988年 / 43卷 / 05期

关键词：

D O I：

10.1038/clpt.1988.78

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：588 / 591

页数：4

共 11 条

[1] STUDIES ON CONDENSED PYRIMIDINE SYSTEMS .21. THE ISOLATION AND SYNTHESIS OF 6-MERCAPTO-2,8-PURINEDIOL (6-THIOURIC ACID) [J].

ELION, GB ;

MUELLER, S ;

HITCHINGS, GH .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1959, 81 (12) :3042-3045

[2] DEPLETION OF ERYTHROCYTE PHOSPHORIBOSYLPYROPHOSPHATE IN MAN - A NEWLY OBSERVED EFFECT OF ALLOPURINOL [J].

FOX, IH ;

WYNGAARD.JB ;

KELLEY, WN .

NEW ENGLAND JOURNAL OF MEDICINE, 1970, 283 (22) :1177-&

[3]

LEVINE AS, 1969, CANCER CHEMOTH REP 1, V53, P53

[4] QUANTITATION OF 6-MERCAPTOPURINE IN BIOLOGIC FLUIDS USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - A SELECTIVE AND NOVEL PROCEDURE [J].

NARANG, PK ;

YEAGER, RL ;

CHATTERJI, DC .

JOURNAL OF CHROMATOGRAPHY, 1982, 230 (02) :373-380

[5]

POMALES R, 1963, BIOCHIM BIOPHYS ACTA, V72, P119

[6]

RAVIS W, 1984, BIOCH PHARM, V3, P443

[7] EFFECTS OF ALLOPURINOL ON 6-MERCAPTOPURINE THERAPY IN NEOPLASTIC DISEASES [J].

RUNDLES, RW .

ANNALS OF THE RHEUMATIC DISEASES, 1966, 25 (6S) :655-&

[8]

VOGLER WR, 1973, AM J MED, V40, P548

[9] VARIABLE BIOAVAILABILITY OF ORAL MERCAPTOPURINE - IS MAINTENANCE CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC-LEUKEMIA BEING OPTIMALLY DELIVERED [J].

ZIMM, S ;

COLLINS, JM ;

RICCARDI, R ;

ONEILL, D ;

NARANG, PK ;

CHABNER, B ;

POPLACK, DG .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (17) :1005-1009

[10] INHIBITION OF 1ST-PASS METABOLISM IN CANCER-CHEMOTHERAPY - INTERACTION OF 6-MERCAPTOPURINE AND ALLOPURINOL [J].

ZIMM, S ;

COLLINS, JM ;

ONEILL, D ;

CHABNER, BA ;

POPLACK, DG .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (06) :810-817

← 1 2 →